Mesa Laboratories, Inc.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.5 EUR
−1.82 M EUR
222.75 M EUR
5.35 M
About Mesa Laboratories, Inc.
Sector
Industry
CEO
Gary M. Owens
Website
Headquarters
Lakewood
Founded
1982
IPO date
Feb 29, 1984
Identifiers
3
ISIN US59064R1095
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Clinical Genomics segment division develops, manufactures and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables and services that enable clinical research labs and contract research organizations. The Biopharmaceutical Development segment caters and sells automated systems for protein analysis and peptide synthesis solutions. The Calibration Solutions segment focuses on the quality control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications such as renal care, environmental and process monitoring, gas flow, air quality and torque testing, primarily in medical device manufacturing, pharmaceutical manufacturing, laboratory and hospital environments. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of MLI is 76.0 EUR — it has increased by 1.30% in the past 24 hours. Watch Mesa Laboratories, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Mesa Laboratories, Inc. stocks are traded under the ticker MLI.
MLI stock has risen by 20.93% compared to the previous week, the month change is a 9.09% rise, over the last year Mesa Laboratories, Inc. has showed a −46.10% decrease.
We've gathered analysts' opinions on Mesa Laboratories, Inc. future price: according to them, MLI price has a max estimate of 97.33 EUR and a min estimate of 79.55 EUR. Watch MLI chart and read a more detailed Mesa Laboratories, Inc. stock forecast: see what analysts think of Mesa Laboratories, Inc. and suggest that you do with its stocks.
MLI stock is 2.63% volatile and has beta coefficient of 1.16. Track Mesa Laboratories, Inc. stock price on the chart and check out the list of the most volatile stocks — is Mesa Laboratories, Inc. there?
Today Mesa Laboratories, Inc. has the market capitalization of 421.12 M, it has decreased by −5.94% over the last week.
Yes, you can track Mesa Laboratories, Inc. financials in yearly and quarterly reports right on TradingView.
Mesa Laboratories, Inc. is going to release the next earnings report on Jun 2, 2026. Keep track of upcoming events with our Earnings Calendar.
MLI earnings for the last quarter are 2.61 EUR per share, whereas the estimation was 1.19 EUR resulting in a 119.29% surprise. The estimated earnings for the next quarter are 1.30 EUR per share. See more details about Mesa Laboratories, Inc. earnings.
Mesa Laboratories, Inc. revenue for the last quarter amounts to 55.45 M EUR, despite the estimated figure of 53.84 M EUR. In the next quarter, revenue is expected to reach 54.73 M EUR.
MLI net income for the last quarter is 3.09 M EUR, while the quarter before that showed 2.11 M EUR of net income which accounts for 46.47% change. Track more Mesa Laboratories, Inc. financial stats to get the full picture.
Yes, MLI dividends are paid quarterly. The last dividend per share was 0.14 EUR. As of today, Dividend Yield (TTM)% is 0.70%. Tracking Mesa Laboratories, Inc. dividends might help you take more informed decisions.
As of Feb 10, 2026, the company has 730 employees. See our rating of the largest employees — is Mesa Laboratories, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Mesa Laboratories, Inc. EBITDA is 35.97 M EUR, and current EBITDA margin is 16.96%. See more stats in Mesa Laboratories, Inc. financial statements.
Like other stocks, MLI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mesa Laboratories, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mesa Laboratories, Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mesa Laboratories, Inc. stock shows the sell signal. See more of Mesa Laboratories, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.